Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Lymphoma, T-Cell, Cutaneous × obinutuzumab × 30 days × Clear all

Sponsor

Conditions

Leukemia, Lymphocytic, Chronic, B-Cell 10 Lymphoma, Non-Hodgkin 9 Lymphoma, Follicular 5 Lymphoma 5 Recurrence 4 Lymphoma, Large B-Cell, Diffuse 4 Neoplasms 2 Lymphoma, Mantle-Cell 2 Lymphoma, B-Cell, Marginal Zone 2 Lymphoma, B-Cell 2 Burkitt Lymphoma 2 Lymphatic Diseases 1 Leukemia, Hairy Cell 1 Leukemia, B-Cell 1 Leukemia 1 Heart Failure 1 Cytokine Release Syndrome 1

Interventions

Specimen Handling 2 Cyclophosphamide 2 Biopsy 2 tazemetostat 1 talimogene laherparepvec 1 fludarabine phosphate 1 fludarabine 1 belinostat 1 Pharmacogenomic Variants 1 Nivolumab 1 Mycophenolic Acid 1 Mesna 1 Melphalan 1 Magnetic Resonance Spectroscopy 1 MEDI-570 1 Filgrastim 1 Bone Marrow Transplantation 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡